We use cookies on our website in order to make your visit more efficient and to offer you the most pleasant possible experience and to analyse the accesses to our website. We use Google Analytics for this purpose. Further information can be found in our DATA PROTECTION STATEMENT.

BDO advises Novartis on the sale of a production plant to Syngenta

18 October 2019

BDO advised Novartis on the sale of a chemical production facility located in the Basel area, Switzerland. With Syngenta Crop Protection, a highly reputable buyer has been found that will manufacture agrochemical active ingredients at the Muttenz/Switzerland plant in the future.

A BDO team led by Hartmut Paulus (Head of BDO Corporate Finance Germany) and Oliver Bach (Corporate Finance/M&A, Frankfurt) advised Novartis on the sale of a chemical production plant to Syngenta Crop Protection AG ("Syngenta").

Over the last 20 years, Novartis has been producing active pharmaceutical ingredients at one of its group-wide largest chemical production plants. The Muttenz/Schweizerhalle site is located on the biggest independent industrial park in Switzerland - InfraPark Baselland AG - and has excellent infrastructure and logistics links.

Syngenta, one of the world’s leading agriculture companies and provider of innovative crop solutions, will take over the plant with its highly flexible and multifunctional production facilities. In the future, Syngenta will manufacture innovative active ingredients and intermediates for crop protection products in the acquired plant.

The team from BDO acted as a Corporate Finance/M&A advisor, in particular managed a structured international investor approach via BDO’s global corporate finance platform comprising of 100 countries around the globe.

With 2,000 corporate finance specialists, BDO Global Corporate Finance is one of the largest and most active corporate finance networks in the world. In 2018, 1,440 transactions were completed worldwide, 222 of them in Europe. According to Refinitiv (formerly Thomson Reuters), BDO occupies a top 5 position in advising on European mid-market M&A transactions.